Quick Navigation

Restless leg syndrome (RLS)

Restless leg syndrome (RLS) is characterized by uncomfortable sensations in the legs that are momentarily relieved upon movement. The sensations typically worsen at night when the legs are at rest, which is incredibly disruptive to sleep quality.

Our evidence-based analysis on restless leg syndrome (rls) features 14 unique references to scientific papers.

Research analysis led by and reviewed by the Examine team.
Last Updated:

Summary of Restless leg syndrome (RLS)

Restless leg syndrome (RLS)[1] is a neurological disorder characterized by uncomfortable sensations in the legs and momentary relief upon movement. The sensations, which are commonly reported[2] as electrical, prickling, burning, tingling, and itching, typically worsen at night, when individuals are more likely to rest. This can be incredibly disruptive to sleep quality, which is why RLS is also classified as a sleep disorder[3].

The condition is estimated to affect 10% of the U.S. population and, as you can see in Figure 1, is more prevalent in women[4] than in men. It’s also more prevalent in individuals of western European descent[5] than those of Asian descent. Researchers believe that there is a strong genetic[6] basis to RLS, since individuals with a family history of RLS are also very likely to have the disorder. Genome-wide association studies[7] have identified variants in six different genes linked to RLS. While much remains unknown, some of these genes have been linked to the development of neurons[8].


Despite this, much evidence[9][10] suggests that dysfunctions in the basal ganglia and in dopamine-producing neurons play roles in the pathology of RLS. These areas are responsible for controlling smooth muscle, which is involved in controlling involuntary movements like those in the digestive tract. Dysfunctions in the brain regions that control these muscles can lead to disruptive involuntary movements. More evidence to support the role of dopamine dysfunction in RLS comes from individuals with Parkinson’s disease, a degenerative condition in which dopamine-producing cells in the brain die at a rapid rate. These individuals are also more likely[11] to develop RLS.

In the past, the American Academy of Sleep Medicine has recommended[12] dopamine agonists (drugs that activate specific dopamine receptors) as evidence-based treatments for RLS in its clinical practice guidelines. A 2011 Cochrane systematic review[13] and meta-analysis of 38 randomized controlled trials found that dopamine-agonists were effective in reducing symptoms of restlessness in individuals with RLS, when compared to placebo. However, participants taking dopamine agonists also had an 82% higher chance of experiencing adverse events, which may make such treatments undesirable for some. Adverse effects such as worsening symptoms over the long term (called “augmentation”) and an increase in impulse control problems led the Restless Leg Syndrome Foundation to downgrade dopamine agonists to a second-line choice for therapy in 2021.[14]

Easily stay on top of the latest nutrition research

Become an Examine Member to get access to the latest research. Get 150+ studies summarized for you across 25 different categories every month.

Members also have access to the Examine Study Database of 400+ supplements and their effects on 600+ health outcomes, as well as in-depth research analyses. Understand the whole body of nutrition and supplement evidence at a glance.

Get instant access — start your free 14-day trial

Already a Member? Click here to log in.


Human Effect Matrix

Unlocked for Examine Members

Easily stay on top of the latest nutrition research

Become an Examine Member to get access to the latest research. Get 150+ studies summarized for you across 25 different categories every month.

Members also have access to the Examine Study Database of 400+ supplements and their effects on 600+ health outcomes, as well as in-depth research analyses. Understand the whole body of nutrition and supplement evidence at a glance.

Get instant access — start your free 14-day trial

Already a Member? Click here to log in.


The Human Effect Matrix looks at human studies to tell you what supplements affect Restless leg syndrome (RLS).

Unlock the full Study Database with an Examine Membership. Get a 14-day free trial.
Grade Level of Evidence
Robust research conducted with repeated double-blind clinical trials
Multiple studies where at least two are double-blind and placebo controlled
Single double-blind study or multiple cohort studies
Uncontrolled or observational studies only
Level of Evidence
? The amount of high quality evidence. The more evidence, the more we can trust the results.
Supplement Magnitude of effect
? The direction and size of the supplement's impact on each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
Consistency of research results
? Scientific research does not always agree. HIGH or VERY HIGH means that most of the scientific research agrees.
Notes
grade-c Minor Moderate See 2 studies
There may be benefits to restless leg syndrome, although this was found only in persons with excessive daytime sleepiness; over the whole group, there was no significant benefit.

Stay on top of the latest research

To unlock the full archives of our Study Database and research analyses, become an Examine Member today.

Start your 14-day free trial

Things to Note

Also Known As

RLS

Click here to see all 14 references.